[253 Pages Report] Global Pharma Grade Synthetic Camphor Market is projected to register the growth of 4.2% CAGR from 2022 to 2028, with an estimated market value of around US$ 532.0 Million in 2028.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Pharma Grade Synthetic Camphor Market Value- Base Year 2021 | US$ 398.3 Million |
| Pharma Grade Synthetic Camphor Market Value - Estimate Year 2022 | US$ 415.4 Million |
| Pharma Grade Synthetic Camphor Market Value- Projected Year 2028 | US$ 532.0 Million |
| CAGR 2022 to 2028 | 4.2% |
| Share of top 5 Countries | 58.3% |
| Key Players | Merck KGaA; Oriental Aromatics Limited; Saptagir Camphor Limited; Mangalam Organics Limited; Nippon Fine Chemical Co., Ltd.; Rochem International, Inc.; Spectrum Chemical Mfg. Corp.; Aldon Corporation; Prinova Group LLC.; Fengchen Group Co.; Ltd.; and Others (100% Market Share) |
As per Future Market Insights’ projections, the topical product holds a substantial share of over 71.5% in 2021 in the overall pharma grade synthetic camphor market.
This surge in use of private labelled topical products containing camphor, increasing rate of self-medication among patients and availability of over-the-counter (OTC) drugs and economic growth is been expected to aid the recovery in certain commodity exports such as camphor.
The global upswing in the investment thus, enthusing the major recovery in mature markets is been witnessed as a critical market driver for the pharma grade synthetic camphor market. However, the shift of positive market sentiments in developing economies, partial recovery in commodity prices are the factors, which are aiding the growth of the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 4.14% |
| H1, 2022 Projected | 4.21% |
| H1, 2022 Outlook | 4.11% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 3 ↓ |
The pharma grade synthetic camphor market is under influence of healthcare expenditure and innovation factors subject to macro and industry factors. Key developments in the market include expansion of manufacturing facilities and exporting products across the globe.
According to FMI analysis, the pharma grade synthetic camphor market will decline by 03 Basis Share Point (BPS) in H1-2022 against H1-2021. A comparison of H1-2022 Outlook and H1-2022 projected growth showed a declining growth with 10 BPS.
Variations in the price of raw materials used in the production of synthetic camphor, which caused many small-scale manufacturers to exit the market, have acted as a restraint on the market's expansion, leading towards a reduction in the BPS value for the pharma grade synthetic camphor market.
Additionally, some hindrances that stay ahead for the industry also include stringent regulatory restrictions for the usage of camphor in pharma grade products. Conversely, other market segments are expected to perform fairly and attain attractive growth prospects in the next half of projection period.
The global pharma grade synthetic camphor market had witnessed a turnaround growth from 2016 onwards, the trend is been expected to continue over the forecast period, which will drive the demand for pharma-grade synthetic camphor. In addition, the incidence rate of several infectious disease is increasing globally. Indications such as respiratory diseases and sexually transmitted diseases are increasing at an alarming rate in countries across the globe.
Highly populated regions such as APAC, MEA and Latin America have high incidence and prevalence of infectious diseases, which in turn is increasing the demand for camphor containing treatment products for infectious disease. Also, surge in use of private labelled topical products containing camphor, which is been driven by positive consumer sentiment and growing demand for topical pain management products are the other factors which are driving the growth of the pharma-grade synthetic camphor market.
The global pharma grade synthetic camphor market constitutes nearly 4.4% of the US$ 9 Bn pharmaceutical excipients market globally in 2021. Private-labelled industry witnessing immense growth in the U.S. market, is been driven by positive consumer sentiment towards such products.
Hence, the demand outlook for pharma grade synthetic camphor market stands expected to grow rapidly during the forecast period from 2022- 2028. The pharma grade synthetic camphor market is expected to expand at a considerable growth rate of around CAGR 4.2%, and observe an incremental $ opportunity of USD 116.6 Mn from 2022 to 2028.
With increasing diseases burden of influenza, the existing cases occurrence owing to the pandemic and market penetration of the players to increase the product accessibility are the factors that are contributing to the growth of the pharma grade synthetic camphor market.
For meeting the increasing demand, the key players are developing new products and expansions both, geographically and by enhancing their product portfolio.
Thus, it offers a great opportunity to the manufacturers of the pharma grade synthetic camphor during the forecast years.
Principal Consultant
The Raw material cost makes up approximately 34–40% of the camphor cost and thus access to high quality raw material at stable prices form a very important aspect of business success
Thus, growing prices of raw materials, i.e., alpha pinene or turpentine oil is a major challenge for the manufacturers of pharma grade synthetic camphor. Fluctuation in the exchange rates is expected to adversely affect the business and hamper the growth of the pharma grade synthetic camphor market. Additionally, regulatory restrictions for use of camphor in pharmaceutical products due to its restricted usage in analgesics will also impede the growth of the market in other product segments.
The COVID-19 outbreak initially affected the pharma grade synthetic camphor market negatively due to the lockdowns imposed in the first half of 2020, which resulted in disruption of the supply chain. While after the upliftment of the lockdown, as a prevention measure to avoid contracting the disease, the upward sale of the over the counter topical formulation products have been registered and trend of stocking of the products were also noted in the market owing to the disease COVID-19.
After facing series of challenges such as supply chain disruption, demand fluctuations and other pressing concerns during 2020, the companies are reviewing their long-term strategies to develop adequate crisis-management strategies that place a premium on next-generation products and solutions pharma grade synthetic camphor.
The R&D funding are being reduced modestly, market trends for pharma grade synthetic camphor are constantly being monitored and companies are also launching marketing initiatives with care, as well as long-term contracts are being strengthened to emerge stronger in the post-COVID pandemic scenario.
However, with the opening of all the economies and the people now adapting to the new normal, the pharma grade synthetic camphor market is been expected to achieve significant growth during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The U.S. is the leading country of the North American region with a total market share of 93.6% in 2021 and projected to continue commanding the high growth during the coming years from 2022- 2028 in pharma grade synthetic camphor market owing to its due to high value and high margins in the market. The growing practice of self-medication with OTC products, increased awareness among the masses for alternative medicine for general flu (symptomatic influenza) and related diseases is set to drive the market during the forecast period.
For instance, as per Centre for Disease Control, the annual incidence of flu cases in the U.S. was 35 million, leading to 380,000 hospital admissions during 2019-2020 year.
In the year 2021, Germany dominates the European market of pharma grade synthetic camphor, with a share of over 23.6% throughout the forecast period owing to the increasing demand of pharma-grade synthetic camphor. According to the World Health Organization (WHO), In Germany, yearly influenza epidemics lead to serious disease and death in high-risk populations. A 30–40 % rate of all influenza cases reported yearly is accounted to occur in the children.
The presence of efficient healthcare infrastructure and the key players in the country are supporting the growth of pharma grade synthetic camphor market growth.
India holds over 55% revenue share in the global market in the year 2021, and projected to expand at a CAGR of 5.4% during the forecast period of 2022-2028. It is been reported that, during 2018-19, Influenza infection in India was estimated as 132 per 1000 child-years. The patient’s positive for influenza in outpatients and inpatients were estimated to be 11.2% and 7.1% (respectively. A total influenza cases during 2018 as 16,009,207 in India. Influenza accounted for 10,913,476 outpatient visits and 1, 09,431 hospitalizations. The high incidence of the disease and deeper penetration of the key players and market accessibility of the products is aiding the growth of pharma grade synthetic camphor market.
In 2021, China has considerable share in the global pharma grade synthetic camphor market of around 13.1% share by value and is projected to expand at a CAGR of 6.1% from 2022-2028. This is predominantly due to the rising number of influenza cases, for instance, as per the recent estimates, influenza-associated mortality rate was found the highest among adults aged ≥ 65 years, the highest influenza disease burden found among people aged ≥ 65 years and < 5 years in China, while the vaccination coverage in the Chinese population was only approximately 2%.
Furthermore, the miniscule penetration of vaccination among the target population poses the risk of infection transmissibility; hence in turn supporting the demand for pharma grade synthetic camphor in the market.
By Formulation type, the topical segment accounts for more than 70% market and is expected to expand at a CAGR of 4.4% during the forecast period from 2022 - 2028.
The topical Product benefits brings direct application on the skin, hence promoting greater absorption, relief from the nasal irritation, reduced side effects and toxicity to other organs and imparting soothing effect. Owing to its natural benefits, it will continue to be the most preferred product among the patients and resulting in growth of pharma grade synthetic camphor market during the forecast period of 2022-2028.
The applications of pharma grade synthetic camphor in treating respiratory disorders is highly preferred and records the share of around 28.6% of the global revenue share in 2021. This trend is expected to continue to grow during the study period. The high share of this segment is attributable to the influenza cases, which affects the respiratory channels of the patients, hence promoting the usage of the synthetic camphor enabled products to be administered in the respiratory cases
Based on the distribution channel, conventional B2B is the leading segment, with nearly 86.5% market share in 2021 due to its improved efficiency, improved awareness, enhanced analytics, and customer-centric experience. Additionally the patients choose OTC product purchases to be conducted at the pharmacies, hence, the significance of the mode of sale channel will maintain its relevancy in the forecast period of 2022-2028 and support the growth of pharma grade synthetic camphor market growth.
The growing share of over the counter purchase and increasing availability of the products at multiple sales channels are the key strategies adopted by manufacturers and integrators for increasing the consumer base in different geographies.
Additionally, Key players are focusing on expansion of their brands and technology in emerging regions by strategic partnerships, and collaborations to strengthen their market presence.
For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 201 to 2021 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Countries Covered | USA, China, India, Japan, Brazil, Germany, France, UK, Mexico, South Africa, Italy, Canada, Argentina, Australia & NZ, Spain South Korea, India, ASEAN, Australia, New Zealand, South Africa, and GCC Countries |
| Key Segments Covered | Formulation type, applications, distribution channel and Region |
| Key Companies Profiled | Merck KGaA; Oriental Aromatics Limited; Saptagir Camphor Limited; Mangalam Organics Limited; Nippon Fine Chemical Co., Ltd.; Rochem International, Inc.; Spectrum Chemical Mfg. Corp.; Aldon Corporation; Prinova Group LLC.; Fengchen Group Co., Ltd |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
By Formulation Type:
By Application:
By Distribution Channels:
By Region:
The global market may account for US$ 532 million by 2028.
The United States may command a leading share in the market through 2033.
Germany may account for 23.6% of the market share.
India and China are pulling up the growth of the global market.
Respiratory disorders segment is likely to hold a notable market share untill 2033.
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Market Background 3.1. Macroeconomic Factors 3.2. Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Trends 3.2.4. Opportunity Analysis 3.3. Macroeconomic Assumptions 3.4. Global Economic Outlook 4. Key Inclusion 4.1. Global Synthetic Camphor Market Analysis 4.2. Regulatory Scenario 4.3. Pricing Analysis, By Region (2021A & 2028F) 5. North America Pharma-Grade Synthetic Camphor Market Analysis 2013-2021 and Forecast 2022-2028 5.1. Introduction 5.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 5.2.1. U.S. 5.2.2. Canada 5.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 5.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 5.4.1. Topical 5.4.2. Inhalation 5.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 5.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 5.6.1. Respiratory Disorders 5.6.2. Muscular Rheumatism 5.6.3. Counterirritant and Antipruritic 5.6.4. Others 5.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 5.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 5.8.1. Conventional B2B 5.8.1.1. Tenders 5.8.1.2. Direct Procurement 5.8.1.3. Wholesalers & Distributors 5.8.2. Online B2B 5.8.2.1. Internal Channel 5.8.2.2. External Channel 5.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 5.10. Market Attractiveness Analysis 5.10.1. By Country 5.10.2. By Formulation Type 5.10.3. By Application 5.10.4. By Distribution Channel 6. Latin America Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 6.1. Introduction 6.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 6.2.1. Brazil 6.2.2. Mexico 6.2.3. Rest of Latin America 6.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 6.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 6.4.1. Topical 6.4.2. Inhalation 6.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 6.6.1. Respiratory Disorders 6.6.2. Muscular Rheumatism 6.6.3. Counterirritant and Antipruritic 6.6.4. Others 6.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 6.8.1. Conventional B2B 6.8.1.1. Tenders 6.8.1.2. Direct Procurement 6.8.1.3. Wholesalers & Distributors 6.8.2. Online B2B 6.8.2.1. Internal Channel 6.8.2.2. External Channel 6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 6.10. Market Attractiveness Analysis 6.10.1. By Country 6.10.2. By Formulation Type 6.10.3. By Application 6.10.4. By Distribution Channel 7. Western Europe Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 7.1. Introduction 7.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 7.2.1. Germany 7.2.2. France 7.2.3. U.K. 7.2.4. Spain 7.2.5. Italy 7.2.6. Rest of Western Europe 7.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 7.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 7.4.1. Topical 7.4.2. Inhalation 7.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 7.6.1. Respiratory Disorders 7.6.2. Muscular Rheumatism 7.6.3. Counterirritant and Antipruritic 7.6.4. Others 7.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 7.8.1. Conventional B2B 7.8.1.1. Tenders 7.8.1.2. Direct Procurement 7.8.1.3. Wholesalers & Distributors 7.8.2. Online B2B 7.8.2.1. Internal Channel 7.8.2.2. External Channel 7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 7.10. Market Attractiveness Analysis 7.10.1. By Country 7.10.2. By Formulation Type 7.10.3. By Application 7.10.4. By Distribution Channel 8. Eastern Europe Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 8.1. Introduction 8.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 8.2.1. Russia 8.2.2. Poland 8.2.3. Rest of Eastern Europe 8.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 8.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 8.4.1. Topical 8.4.2. Inhalation 8.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 8.6.1. Respiratory Disorders 8.6.2. Muscular Rheumatism 8.6.3. Counterirritant and Antipruritic 8.6.4. Others 8.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 8.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 8.8.1. Conventional B2B 8.8.1.1. Tenders 8.8.1.2. Direct Procurement 8.8.1.3. Wholesalers & Distributors 8.8.2. Online B2B 8.8.2.1. Internal Channel 8.8.2.2. External Channel 8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 8.10. Market Attractiveness Analysis 8.10.1. By Country 8.10.2. By Formulation Type 8.10.3. By Application 8.10.4. By Distribution Channel 9. Asia Pacific excluding China & Japan (APECJ) Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 9.1. Introduction 9.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 9.2.1. India 9.2.2. Australia and New Zealand 9.2.3. ASEAN 9.2.4. Rest of APEJ 9.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 9.4. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 9.5. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 9.5.1. Topical 9.5.2. Inhalation 9.6. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 9.7.1. Respiratory Disorders 9.7.2. Muscular Rheumatism 9.7.3. Counterirritant and Antipruritic 9.7.4. Others 9.8. Market Size (US$ Mn) Forecast By Application, 2022-2028 9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 9.9.1. Conventional B2B 9.9.1.1. Tenders 9.9.1.2. Direct Procurement 9.9.1.3. Wholesalers & Distributors 9.9.2. Online B2B 9.9.2.1. Internal Channel 9.9.2.2. External Channel 9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 9.11. Market Attractiveness Analysis 9.11.1. By Country 9.11.2. By Formulation Type 9.11.3. By Application 9.11.4. By Distribution Channel 10. Japan Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 10.2.1. Topical 10.2.2. Inhalation 10.3. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 10.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 10.4.1. Respiratory Disorders 10.4.2. Muscular Rheumatism 10.4.3. Counterirritant and Antipruritic 10.4.4. Others 10.5. Market Size (US$ Mn) Forecast By Application, 2022-2028 10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 10.6.1. Conventional B2B 10.6.1.1. Tenders 10.6.1.2. Direct Procurement 10.6.1.3. Wholesalers & Distributors 10.6.2. Online B2B 10.6.2.1. Internal Channel 10.6.2.2. External Channel 10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 10.8. Market Attractiveness Analysis 10.8.1. By Formulation Type 10.8.2. By Application 10.8.3. By Distribution Channel 11. China Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 11.2.1. Topical 11.2.2. Inhalation 11.3. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 11.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 11.4.1. Respiratory Disorders 11.4.2. Muscular Rheumatism 11.4.3. Counterirritant and Antipruritic 11.4.4. Others 11.5. Market Size (US$ Mn) Forecast By Application, 2022-2028 11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 11.6.1. Conventional B2B 11.6.1.1. Tenders 11.6.1.2. Direct Procurement 11.6.1.3. Wholesalers & Distributors 11.6.2. Online B2B 11.6.2.1. Internal Channel 11.6.2.2. External Channel 11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 11.8. Market Attractiveness Analysis 11.8.1. By Formulation Type 11.8.2. By Application 11.8.3. By Distribution Channel 12. MEA Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 12.1. Introduction 12.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 12.2.1. GCC Countries 12.2.2. South Africa 12.2.3. Rest of MEA 12.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 12.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 12.4.1. Topical 12.4.2. Inhalation 12.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 12.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 12.6.1. Respiratory Disorders 12.6.2. Muscular Rheumatism 12.6.3. Counterirritant and Antipruritic 12.6.4. Others 12.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 12.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 12.8.1. Conventional B2B 12.8.1.1. Tenders 12.8.1.2. Direct Procurement 12.8.1.3. Wholesalers & Distributors 12.8.2. Online B2B 12.8.2.1. Internal Channel 12.8.2.2. External Channel 12.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 12.10. Market Attractiveness Analysis 12.10.1. By Country 12.10.2. By Formulation Type 12.10.3. By Application 12.10.4. By Distribution Channel 13. Forecast Factors: Relevance and Impact 14. Competition Analysis 14.1. Competition Development Snapshot 14.2. Competition Dashboard 14.3. Company Deep Dive (Company Overview, Product portfolio, Strategy, Company Footprint) 14.3.1. Merck KGaA 14.3.2. Oriental Aromatics Limited 14.3.3. Saptagir Camphor Limited 14.3.4. Mangalam Organics Limited 14.3.5. Fengchen Group Co., Ltd. 14.3.6. Nippon Fine Chemical Co., Ltd. 14.3.7. Rochem International, Inc. 14.3.8. Spectrum Chemical Mfg. Corp. 14.3.9. Aldon Corporation 14.3.10. Prinova Group LLC. 15. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Region 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Region, 2013-2021 15.2.1. North America 15.2.2. Western Europe 15.2.3. Eastern Europe 15.2.4. Latin America 15.2.5. Asia Pacific excluding Japan and China 15.2.6. Japan 15.2.7. China 15.2.8. Middle East and Africa 15.3. Market Size (US$ Mn) and Volume (MT) Forecast By Region, 2022-2028 15.4. Market Attractiveness Analysis By Region 16. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Formulation Type 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Trend Analysis By Formulation Type, 2013-2021 16.2.1. Topical 16.2.2. Inhalation 16.3. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 16.4. Market Attractiveness Analysis By Formulation Type 17. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Application 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 17.2.1. Respiratory Disorder 17.2.2. Muscular Rheumatism 17.2.3. Counterirritant and Antipruritic 17.2.4. Others 17.3. Market Size (US$ Mn) Forecast By Application, 2022-2028 17.4. Market Attractiveness Analysis By Application 18. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Distribution Channel 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 18.2.1. Conventional B2B 18.2.1.1. Tenders 18.2.1.2. Direct Procurement 18.2.1.3. Wholesalers & Distributors 18.2.2. Online B2B 18.2.2.1. Internal Channel 18.2.2.2. External Channel 18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 18.4. Market Attractiveness Analysis By Distribution Channel 19. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 19.1. Market Value Share Analysis 19.1.1. By Country 19.1.2. By Formulation Type 19.1.3. By Application 19.1.4. By Distribution Channel 19.2. Y-o-Y Growth Analysis 19.3. Absolute $ Opportunity 20. Assumptions and Acronyms Used 21. Research Methodology
Healthcare
February 2021
REP-GB-13025
June 2023
273 pages
Explore Healthcare Insights
View Reports
Pharma Grade Synthetic Camphor Market
